Can You Take Amlodipine and Simvastatin Together?

Amlodipine and simvastatin can be taken together, but the combination requires careful dose management. According to FDA guidance, when these two drugs are used at the same time, the maximum daily dose of simvastatin should not exceed 20 mg. This restriction exists because the pairing increases the risk of muscle damage, a condition called myopathy, which in severe cases can progress to rhabdomyolysis—a breakdown of muscle tissue that can cause kidney damage.

What the Source Says

The FDA drug label for amlodipine identifies simvastatin as an interacting medication and specifies the dose adjustment requirement. The label categorizes this interaction under "Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis." According to the prescribing information:

• Severity level: The interaction warrants a dose-restriction recommendation, placing it among the more serious drug combinations requiring active management.
• Specific guidance: When amlodipine is used with simvastatin, the simvastatin dose should not exceed 20 mg daily.
• Risk identified: The pairing increases the risk of myopathy (muscle pain and weakness) and rhabdomyolysis (severe muscle breakdown).
• Source: This information comes directly from FDA-approved drug labeling for amlodipine, making it a regulatory safety statement rather than a research finding or clinical opinion.

The label further notes that other calcium channel blockers—specifically verapamil and diltiazem—carry similar restrictions with simvastatin, and that amiodarone and ranolazine also fall into the same risk category.

How to Understand This

Why Does This Interaction Occur?

The FDA-supplied interaction record does not specify a documented mechanism explaining how amlodipine increases the risk of simvastatin-related muscle damage. This is important to understand: the absence of a stated mechanism does not mean the interaction is speculative or unproven. The FDA identifies the interaction based on clinical and pharmacological evidence—but the exact biological pathway is not detailed in this particular source document.

General background on statin pharmacology may help contextualize why dose limits matter: Simvastatin is metabolized (broken down) primarily by an enzyme system in the liver called CYP3A4. Anything that slows this metabolism can cause simvastatin to accumulate in the bloodstream, raising the risk of muscle toxicity. Some strong CYP3A4 inhibitors—such as certain antifungal drugs, antibiotics, and protease inhibitors—are listed as contraindicated (absolutely not recommended) with simvastatin at any dose. Amlodipine does not rise to that level of severity, but the FDA guidance recognizes that the combination warrants dose reduction.

Why Is 20 mg the Threshold?

The 20 mg daily limit for simvastatin when taken with amlodipine is a regulatory safety recommendation, not a theoretical threshold. This dose has been established through FDA review of safety data and clinical experience. Staying within this limit reduces—though does not eliminate—the risk of myopathy and rhabdomyolysis. Many patients are started on simvastatin 10–20 mg daily regardless of drug interactions, so this restriction may not require a dose change if you are already on a lower dose. However, if you were prescribed a higher dose of simvastatin before starting amlodipine, or if both drugs are being started together, your dose will need to be adjusted downward to comply with this guidance.

Who Should Pay Particular Attention

The FDA source record does not specify which patient populations face higher or lower risk within the amlodipine–simvastatin combination. However, general clinical considerations apply:

• Patients with kidney disease: Kidney function affects how both drugs are cleared from the body, and impaired kidney function can increase the accumulation of either drug.
• Older adults: Age-related changes in liver and kidney function may affect how quickly these drugs are metabolized and cleared.
• Patients taking multiple medications: Other drugs that interact with simvastatin (such as certain antibiotics, antifungals, or other cardiovascular medications) could compound the risk.
• Patients with a personal or family history of statin-related muscle problems: Prior muscle symptoms or myopathy increase individual vulnerability to recurrence.

These considerations should be discussed with your pharmacist or physician, who can assess your individual risk profile and medication list.

Hypothetical Examples

Example 1: Starting Both Medications Together

Suppose a patient is newly diagnosed with high blood pressure and high cholesterol and is prescribed amlodipine 5 mg daily and simvastatin 40 mg daily. At the first refill or follow-up appointment, the pharmacist or physician would need to reduce the simvastatin dose to a maximum of 20 mg daily to comply with FDA guidance for this combination. The reason is not that the patient is at higher-than-average risk, but that FDA safety labeling requires this dose restriction whenever these two drugs are used together.

Example 2: Adding Amlodipine to Existing Simvastatin

Suppose a patient has been taking simvastatin 40 mg daily for several years for cholesterol management, with good tolerance and no muscle symptoms. A physician then prescribes amlodipine 5 mg daily to treat newly diagnosed high blood pressure. In this scenario, the simvastatin dose would need to be reduced to 20 mg daily or lower, even though the patient had previously tolerated the higher dose without simvastatin alone. The interaction with amlodipine creates a new safety parameter that overrides the patient's prior dose history.

What to Discuss With a Pharmacist or Physician

If you are currently taking or are about to start both amlodipine and simvastatin, consider asking your healthcare provider or pharmacist:

• "What is my current simvastatin dose, and does it comply with the 20 mg daily maximum recommended when taking amlodipine?" This is a factual question about whether your existing prescription aligns with FDA guidance.
• "If I am on a simvastatin dose higher than 20 mg, what dose adjustment is recommended?" Your pharmacist can explain any planned dose change and when it takes effect.
• "Are there other medications in my list that also interact with simvastatin?" Amlodipine is one of several drugs that require simvastatin dose reduction; your full medication list may have additional interactions.
• "What symptoms should I watch for?" Muscle pain, weakness, or dark urine can signal myopathy or rhabdomyolysis and require urgent medical attention.
• "How often should my muscle symptoms or kidney function be monitored while on this combination?" Your physician may recommend periodic lab work or clinical assessment, depending on your individual risk factors.
• "Are there alternative blood pressure medications or cholesterol medications I could use instead?" Your doctor can discuss whether a different drug pairing might avoid or reduce this interaction, depending on your clinical condition and other factors.

These are informational questions to help you understand your medication plan. Do not change or stop any medication without explicit guidance from your prescriber or pharmacist.

Key Takeaways

• Amlodipine and simvastatin can be used together, but FDA guidance requires that simvastatin not exceed 20 mg daily when amlodipine is also prescribed.
• The combination increases the risk of myopathy (muscle pain and weakness) and rhabdomyolysis (severe muscle breakdown), which is why dose adjustment is necessary.
• The FDA source record does not specify the precise mechanism by which amlodipine increases simvastatin-related muscle risk, but the interaction is documented and the dose restriction is a regulatory safety requirement.
• If you are already taking simvastatin at a dose higher than 20 mg daily and your physician prescribes amlodipine, or vice versa, your dose will likely need to be adjusted to meet this guidance.
• Muscle pain, weakness, or dark urine while on this combination warrant immediate medical attention, as they may signal dangerous muscle breakdown. Discuss any new or worsening symptoms with your healthcare provider right away.

Sources

• FDA Orange Book and Drug Labeling: DailyMed (National Library of Medicine) — Search for amlodipine or simvastatin to access current FDA-approved prescribing information and drug interaction sections.
• NLM RxNorm: RxNorm Database — Official source for drug naming, relationships, and interaction alerts from the National Library of Medicine.
• FDA Drug Interactions: OpenFDA — Searchable FDA drug safety and adverse event data.
• FDA Adverse Event Reporting System (FAERS): FAERS Public Dashboard — Reports of adverse events associated with drugs and biologics.
• Medline Plus (Consumer Health Information): MedlinePlus — Patient-friendly summaries of drug information and interactions.

To check for interactions with your complete medication list and confirm that your current dose regimen aligns with FDA safety guidance, visit checkdruginteractions.com. Always confirm any medication decisions—including dose changes, additions, or discontinuations—with your pharmacist or physician before making changes to your medication routine.